Skip to content
Screener

ICU Medical ICUI Financing Cash Flow

Financing Cash Flow at other companies

Baxter International logo
Baxter InternationalBAX
-$11M+99.7%
Moog Inc. logo
Moog Inc.MOG.A
$137.02M
TFX
TeleflexTFX
-$82M-246%
Edwards Lifesciences logo
Edwards LifesciencesEW
-$451.2M-74.9%
AngioDynamics logo
AngioDynamicsANGO
$621K-91.3%
Medtronic logo
MedtronicMDT
-$888M+33.9%

Other financials

Income statement

See full
Revenue$551.7M+0.5%
Gross profit$235.1M+13.0%
Operating income$39.1M+270%
Net income$19.1M-46.0%
EPS (diluted)$0.76-46.9%

Balance sheet

See full
Cash & equivalents$298.3M-0.6%
Total debt$1.3B-7.1%
Total equity$2.2B+1.7%
Total assets$4.0B-3.3%

Cash flow

See full
Operating cash flow$80.2M+615%
CapEx$18.5M-6.0%
Free cash flow$61.6M

Valuation

See full
Market cap$4.16B+33.1%
Enterprise value$5.17B+22.2%
P/E51.2×
P/S1.9×+0.6×

Profitability

See full
Gross margin39.1%+3.3pp
Operating margin3.3%+0.4pp
Net margin-0.3%-0.2pp
FCF margin7.1%+4.2pp

Returns & leverage

See full
Return on equity-0.4%-0.2pp
Debt / equity0.6×-0.1×
Current ratio2.4×0.0×

Where this comes from

Reported directly by ICU Medical in its filing.

Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInFinancingActivities.

The source filing: ICU Medical’s 10-Q, filed August 6, 2026.

Filed
Aug 6, 2026, 4:34 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0000883984-26-000041
Line itemSix months ended June 30, 2026Six months ended June 30, 2025
Proceeds from exercise of stock options4905,972
Payments on finance leases(1,297)(885)
Tax withholding payments related to net share settlement of equity awards(38,862)(8,688)
Net cash used in financing activities(94,357)(251,351)
Effect of exchange rate changes on cash(3,020)9,624
NET DECREASE IN CASH AND CASH EQUIVALENTS(9,664)(8,541)
CASH AND CASH EQUIVALENTS, beginning of period307,963308,566
CASH AND CASH EQUIVALENTS, end of period$298,299$300,025

Item 1. Financial Statements (Unaudited)

FAQ

What is ICU Medical's financing cash flow?
ICU Medical (ICUI) reported financing cash flow of -$50.24M in Q2 2026.
How has ICU Medical's financing cash flow changed year-over-year?
ICU Medical's financing cash flow increased by 74.2% year-over-year, from -$195.02M to -$50.24M.
What is the long-term trend for ICU Medical's financing cash flow?
Over 2 years (2023 to 2025), ICU Medical's financing cash flow has grown at a 194.3% compound annual growth rate (CAGR), from -$35.98M to -$311.53M.
What does financing cash flow mean?
Total net cash provided by or used in financing activities — debt issuance/repayment, equity transactions, and dividend payments.

Ask your AI about ICU Medical's financing cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude